Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2
F. Tian, Bei Tong, Liang Sun, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 329

Showing 1-25 of 329 citing articles:

Mechanisms of SARS-CoV-2 entry into cells
Cody B. Jackson, Michael Farzan, Bing Chen, et al.
Nature Reviews Molecular Cell Biology (2021) Vol. 23, Iss. 1, pp. 3-20
Open Access | Times Cited: 2410
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
Wilfredo F. García-Beltrán, Kerri St. Denis, Angelique Hœlzemer, et al.
Cell (2022) Vol. 185, Iss. 3, pp. 457-466.e4
Open Access | Times Cited: 1020
SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein–ACE2 complex
Dhiraj Mannar, James W. Saville, Xing Zhu, et al.
Science (2022) Vol. 375, Iss. 6582, pp. 760-764
Open Access | Times Cited: 610
Omicron and Delta variant of SARS‐CoV‐2: A comparative computational study of spike protein
Suresh Kumar, Thiviya S. Thambiraja, Kalimuthu Karuppanan, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 4, pp. 1641-1649
Open Access | Times Cited: 515
Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species
Ruoke Wang, Qi Zhang, Jiwan Ge, et al.
Immunity (2021) Vol. 54, Iss. 7, pp. 1611-1621.e5
Open Access | Times Cited: 227
Omicron (BA.1) and sub‐variants (BA.1.1, BA.2, and BA.3) of SARS‐CoV‐2 spike infectivity and pathogenicity: A comparative sequence and structural‐based computational assessment
Suresh Kumar, Kalimuthu Karuppanan, Gunasekaran Subramaniam
Journal of Medical Virology (2022) Vol. 94, Iss. 10, pp. 4780-4791
Open Access | Times Cited: 189
SARS‐CoV‐2 Alpha, Beta, and Delta variants display enhanced Spike‐mediated syncytia formation
Maaran Michael Rajah, Mathieu Hubert, Elodie Bishop, et al.
The EMBO Journal (2021) Vol. 40, Iss. 24
Open Access | Times Cited: 171
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Wei-Yu Chi, Yen-Der Li, Hsin‐Che Huang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 166
A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson
Rikinkumar S. Patel, Mohamad Kaki, Venkat Sumanth Potluri, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 1
Open Access | Times Cited: 155
Structural and functional impact by SARS-CoV-2 Omicron spike mutations
Jun Zhang, Yongfei Cai, Christy L. Lavine, et al.
Cell Reports (2022) Vol. 39, Iss. 4, pp. 110729-110729
Open Access | Times Cited: 138
The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK
Verity Hill, Louis du Plessis, Thomas P. Peacock, et al.
Virus Evolution (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 127
Variants with the N501Y mutation extend SARS-CoV-2 host range to mice, with contact transmission
Xavier Montagutelli, Matthieu Prot, Laurine Levillayer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 120
A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations
Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 118
Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants
Anshumali Mittal, Arun Khattri, Vikash Verma
PLoS Pathogens (2022) Vol. 18, Iss. 2, pp. e1010260-e1010260
Open Access | Times Cited: 115
Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape
Zhennan Zhao, Jingya Zhou, Mingxiong Tian, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 114
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
Wilfredo F. García-Beltrán, Kerri St. Denis, Angelique Hœlzemer, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 104
SARS-CoV-2 Omicron Variant: Epidemiological Features, Biological Characteristics, and Clinical Significance
Yifei Guo, Jiajia Han, Yao Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 101
Cryo-EM structure of the SARS-CoV-2 Omicron spike
Gabriele Cerutti, Yicheng Guo, Lihong Liu, et al.
Cell Reports (2022) Vol. 38, Iss. 9, pp. 110428-110428
Open Access | Times Cited: 94
Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants
Clauber Henrique Souza da Costa, Camila Auad Beltrão de Freitas, Cláudio Nahum Alves, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 78
Determinants of Spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2
Chiara Pastorio, Fabian Zech, Sabrina Noettger, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 9, pp. 1255-1268.e5
Open Access | Times Cited: 74
A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy
Allison J. Greaney, Tyler N. Starr, Rachel Eguia, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 2, pp. e1010248-e1010248
Open Access | Times Cited: 67
From Alpha to Omicron: How Different Variants of Concern of the SARS-Coronavirus-2 Impacted the World
Mickensone Andre, Lee-Seng Lau, Marissa D. Pokharel, et al.
Biology (2023) Vol. 12, Iss. 9, pp. 1267-1267
Open Access | Times Cited: 43
An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial
Amit Saraf, Rohan Gurjar, Swarnendu Kaviraj, et al.
Nature Medicine (2024) Vol. 30, Iss. 5, pp. 1363-1372
Open Access | Times Cited: 19
Pathophysiological, immunological, and inflammatory features of long COVID
Karen Böhmwald, Benjamín Diethelm‐Varela, Linmar Rodríguez-Guilarte, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 17
Molecular insights into the adaptive evolution of SARS-CoV-2 spike protein
Zhuocheng Yao, Lin Zhang, Yuange Duan, et al.
Journal of Infection (2024) Vol. 88, Iss. 3, pp. 106121-106121
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top